Andre Paes

Prof. Andre Paes

Case Western Reserve University
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2022 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
GLGretchen A Lam
Gretchen A Lam
HAHala Albarrak
Hala Albarrak
CMCassidy J McColl
Cassidy J McColl
APAlaina Pizarro
Alaina Pizarro
HSHarsha Sanaka
Harsha Sanaka
APAndre Paes
Andre Paes
One of the prospective sequelae of periodontal disease (PD), chronic inflammation of the oral mucosa, is the development of inflammatory gastrointestinal (GI) disorders due to the amplification and expansion of the oral pathobionts. In addition, chronic inflammatory diseases related to the GI tract, which include inflammatory bowel disease (IBD), can lead to malignancy susceptibility in the colon of both animals and humans. Recent studies suggest that dysbiosis of the oral microbiota can alter the microbial composition in relative abundance or diversity of the distal gut, leading to the progression of digestive carcinogenesis. The link between PD and specific GI disorders is also closely associated with the migration and colonization of periodontal pathogens and the subsequent microbe-reactive T cell induction within the intestines. In this review, an in-depth examination of this relationship and the accessibility of different mouse models of IBD and PD may shed light on the current dogma. As such, oral microbiota dysbiosis involving specific bacteria, including Fusobacterium nucleatum and Porphyromonas gingivalis, can ultimately lead to gut malignancies. Further understanding the precise mechanism(s) of the oral-gut microbial axis in PD, IBD, and colorectal cancer pathogenesis will be pivotal in diagnosis, prognosis, and future treatment.

19 July 2022 in Journal of Periodontology
Verified
Journal Article
Open access
AEAyaz Enver
Ayaz Enver
NONurdan Ozmeric
Nurdan Ozmeric
SISila Cagri Isler
Sila Cagri Isler
MTMurat Toruner
Murat Toruner
CFCigdem Fidan
Cigdem Fidan
APAndre Paes
Andre Paes
Background: Periodontal diseases and inflammatory bowel diseases (IBD, ulcerative colitis [UC] and Crohn disease [CD]) have been reported to present with increased salivary and gingival crevicular fluid (GCF) concentrations of cytokines. The aim of this study was to evaluate the salivary and GCF levels of TNF‐α, IL‐1β, IL‐10, and IL‐17A and their associations with the periodontal statuses of UC, CD, and non‐IBD patients, and to analyze the interrelationships among these cytokines, IBD conditions, and periodontal diseases.Methods: This cross‐sectional study was performed with a total of 131 patients (62 women and 69 men, mean age 42.96±13.02 years). Patients were divided into three groups: UC, CD, and non‐IBD. Periodontal status was defined according to the 2017 World Workshop Disease Classification. Salivary and GCF cytokine levels were analyzed using ELISA.Results: UC and CD patients diagnosed as having periodontitis and gingivitis presented with significantly higher levels of TNF‐α and lower levels of IL‐10 as compared with non‐IBD patients (p<0.05). UC patients diagnosed with periodontitis exhibited significantly higher scores of bleeding on probing (p = 0.011) and increased salivary and GCF IL‐1β levels as compared with CD patients (p = 0.005, and 0.012, respectively). Considering the active and remission status of IBD, salivary IL‐1β was found to be correlated with the parameters representing the severity of periodontal diseases in active UC and CD patients.Conclusion: In the presence of periodontal diseases, UC and CD patients showed different expression levels of TNF‐α, IL‐1β, and IL‐10 in oral secretions as compared with non‐IBD patients.

5 September 2021 in Cureus
Verified
Journal Article
Open access
LALeela Subhashini C. Alluri
Leela Subhashini C. Alluri
APAndre Paes
Andre Paes
Shiv Shankar VermaShiv Shankar Verma
Shiv Shankar Verma
PFPingfu FU
Pingfu FU
DSDaniel Lee Shen
Daniel Lee Shen
NBNabil F. Bissada
Nabil F. Bissada
Intraprostatic inflammation is frequently observed in the prostate and linked to prostatic diseases, including prostatitis, benign prostatic hyperplasia (BPH), and cancer. The etiology of prostate diseases is unclear. Periodontal diseases are associated with an increased risk of prostate diseases. In men, chronic prostatitis and moderate/severe periodontitis have significantly elevated serum prostate-specific antigen (PSA) levels. Treatment of periodontal disease reduced PSA levels in men. The presence of periodontal pathogens deoxyribonucleic acid (DNA) was identified in the prostate fluid of prostatitis patients. These pathogenic bacteria might have the potential to trigger prostatitis progressing to prostatic adenocarcinoma. The mechanism(s) explaining the etiology of association between periodontal disease and prostate cancer remains unclear. However, the presence of periodontal pathogens has not been analyzed in the prostate gland. To identify and compare the presence of specific periodontal pathogens in the areas of BPH, inflammation, and cancer of the prostate glands diagnosed with malignancy. Whole-mount radical prostatectomy sections from men (n=30) were identified for BPH, inflammation, and cancer areas and marked for tissue procurement. The tissues were subjected to DNA isolation and analysis of microbial DNA and total bacterial load for the following pathogens, including Porphyromonas gingivalis strain ATCC 33277, Prevotella intermedia strain B422, Treponema denticola strain 35405, Fusobacterium nucleatum subsp. fusiform strain, Tannerella forsythia strain ATCC 43037, and Campylobacter​​​​​​​ rectus strain ATCC 33238 performed real-time PCR. The universal bacterial primer pairs were used to detect genomic DNA (gDNA) from the total bacteria present in the samples. All species-specific primers were designed to target the variable regions of the 16S ribosomal RNA (rRNA). Data were analyzed using the 2-ΔΔCT method, statistically validated using unpaired t-test and ANOVA test. A total of 90 samples of prostate tissue specimens were analyzed for periodontal pathogens; only one pathogen (F. nucleatum subsp. fusiform strain ATCC 51190) showed a significant difference compared to the expression of S. epidermidis (internal control). In particular, F. nucleatum expression was 9, 11.9, and 10.3-fold higher in BPH, inflammation, and cancer, respectively, at p-value 0.05). Similarly, there was no significant difference between F. nucleatum (folder change) among the three areas (p-valve>0.05). Fusobacterium nucleatum is identified in the prostates that harbor cancer, chronic inflammation, and BPH.

28 January 2022 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
MTMiriam Ting
Miriam Ting
LALeela Subhashini Choudary Alluri
Leela Subhashini Choudary Alluri
JSJohn G Sulewski
John G Sulewski
Jon B SuzukiJon B Suzuki
Jon B Suzuki
APAndre Paes
Andre Paes
(1) Background: This systematic review aimed to evaluate the effects of laser therapy on radiographic bone level (RBL) changes in peri-implantitis defects. (2) Methods: A literature search with defined inclusion criteria was performed. PubMed, Web of Science, Cochrane Library, and Google Scholar were searched through September 2020. The evaluated primary outcomes were RBL changes. In studies that reported RBL data, corresponding secondary clinical outcomes were probing depth (PD), bleeding on probing (BOP), and clinical attachment level (CAL). (3) Results: Thirteen articles were selected for data extraction and risk of bias assessment. Eight studies showed evidence of RBL gain in the laser groups compared to baseline, but did not report the statistical significance. Eight of these 13 studies reported comparisons to control. Five of the eight studies did not show RBL gain in the laser groups compared to control. In the laser groups compared to baseline, 11 of 13 reported reduced PD, and 6 of 13 reported significantly reduced BOP. Compared to the control, eight of the eight reported reduction of PD, and three of six reported significantly reduced BOP. Statistical significance was not consistently reported. (4) Conclusions: Within the limits of this systematic review, laser treatment may promote bone gain in peri-implantitis defects, may reduce BOP and PDs, and may be comparable to mechanical therapy. However, definitive conclusions can only be made with statistically significant data, which were found lacking in the currently available studies. This systematic review was registered with the National Institute for Health Research, international prospective register of systematic reviews (PROSPERO): CRD42020207972.

1 January 2019
Verified
Journal Article
Closed access
APAndre Paes
Andre Paes
LALeela Subhashini Choudary Alluri
Leela Subhashini Choudary Alluri
NBNabil F. Bissada
Nabil F. Bissada
SGSanjay Gupta
Sanjay Gupta

1 April 2018
Verified
Journal Article
Closed access
NONurdan Ozmeric
Nurdan Ozmeric
NBNabil Bissada
Nabil Bissada
APAndre Paes
Andre Paes